Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma
Clinical trial NCT03287817 · TERMINATED
Trial details
- NCT number
- NCT03287817
- Sponsor
- Autolus Limited
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-05
- Primary completion
- 2023-10-19
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.